Abstract

Background: Critically ill patients with coronavirus disease 2019 (COVID-19) and kidney dysfunction often require tunneled hemodialysis catheter (TDC) placement for kidney replacement therapy, typically under fluoroscopic guidance to minimize catheter-related complications. This entails transportation of patients outside the intensive care unit to a fluoroscopy suite, which may potentially expose many healthcare providers to COVID-19. One potential strategy to mitigate the risk of viral transmission is to insert TDCs at the bedside, using ultrasound and anatomic landmarks only, without fluoroscopic guidance. Methods: We reviewed all COVID-19 patients in the intensive care unit who underwent right internal jugular TDC insertion at the bedside between April and December 2020. Outcomes included catheter placement-related complications such as post-procedural bleeding, air embolism, dysrhythmias, pneumothorax/hemothorax, and catheter tip malposition. TDC insertion was considered successful if the catheter was able to achieve blood flow sufficient to perform either a single intermittent or 24 h of continuous hemodialysis treatment. Results: We report a retrospective, single-center case series of 25 patients with COVID-19 who had right internal jugular TDCs placed at the bedside, 10 of whom underwent simultaneous insertion of small-bore right internal jugular tunneled central venous catheters for infusion. Continuous veno-venous hemodialysis was utilized for kidney replacement therapy in all patients, and a median catheter blood flow rate of 200 mL/min (IQR: 200–200) was achieved without any deviation from the dialysis prescription. No catheter insertion-related complications were observed, and none of the catheter tips were malpositioned. Conclusions: Bedside right internal jugular TDC placement in COVID-19 patients, using ultrasound and anatomic landmarks without fluoroscopic guidance, may potentially reduce the risk of COVID-19 transmission among healthcare workers without compromising patient safety or catheter function. Concomitant insertion of tunneled central venous catheters in the right internal jugular vein for infusion may also be safely accomplished and further help limit personnel exposure to COVID-19.

Highlights

  • The global coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed unique challenges for infection prevention and control within healthcare facilities [1]

  • One potential strategy to limit the exposure of multiple hospital staff members to COVID-19 involves bedside placement of tunneled hemodialysis catheter (TDC) in the intensive care unit (ICU) under continuous cardiac monitoring, using anatomic landmarks and ultrasound only, without fluoroscopic guidance [7]

  • A total of 25 patients infected with COVID-19 who underwent right internal jugular (IJ) TDC placement at the bedside in the ICU between 1 April and 31 December 2020, utilizing only anatomic landmarks and ultrasound for real-time guidance without fluoroscopy, were included in the analysis

Read more

Summary

Introduction

The global coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed unique challenges for infection prevention and control within healthcare facilities [1]. The standard clinical practice for TDC placement involves using ultrasound and fluoroscopic guidance, ensuring minimal immediate procedural complications with appropriate catheter tip positioning in the mid-right atrium [6] This entails transporting the patient from the ICU to a fluoroscopy suite and potentially exposing numerous healthcare professionals and ancillary staff to SARS-CoV-2-infected patients [2]. Ill patients with coronavirus disease 2019 (COVID-19) and kidney dysfunction often require tunneled hemodialysis catheter (TDC) placement for kidney replacement therapy, typically under fluoroscopic guidance to minimize catheter-related complications. This entails transportation of patients outside the intensive care unit to a fluoroscopy suite, which may potentially expose many healthcare providers to COVID-19. Concomitant insertion of tunneled central venous catheters in the right internal jugular vein for infusion may be safely accomplished and further help limit personnel exposure to COVID-19

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call